Research Article | Open Access
Maryam Nikkhoo, Qasem Asgari, Mahmood Reza Moein, Kambiz Yaghoobi, Abbas Gholipour, "In Vitro and In Vivo Survey of Ethyl Acetate Extract of Acorus calamus (Sweet Flag) Rhizome on Toxoplasma gondii", Journal of Parasitology Research, vol. 2021, Article ID 6656023, 7 pages, 2021. https://doi.org/10.1155/2021/6656023
In Vitro and In Vivo Survey of Ethyl Acetate Extract of Acorus calamus (Sweet Flag) Rhizome on Toxoplasma gondii
Background. Toxoplasmosis is a zoonosis disease that can cause a variety range of manifestations in human specially fetus duration and immunodeficiency conditions. Due to toxicity and side effects of current treatment, we evaluated in vivo and in vitro effects of ethyl acetate extract of Acorus calamus rhizomes (rootstocks) on Toxoplasma gondii. Methods. The plant, Acorus calamus, was collected from Sari, North of Iran in spring season. Ethyl acetate extract was provided from plant rhizomes using Soxhlet apparatus. The total phenolic and flavonoid contents of the extract were measured by the Folin–Ciocalteu method. The mortality effect of different concentrations (1-256 μg/ml) of the extract on Toxoplasma tachyzoites was assessed by flowcytometry and propidium iodide staining. For the therapeutic effect assessment, the tachyzoites were inoculated intraperitoneally to mice, and then these mice were orally and intraperitoneally administered different concentrations (32, 64, 128, and 256 mg/kg) of the extract. Also, an infected group received PBS including DMSO 1% as negative control, and an infected group administered sulfadiazine as positive control. For toxicity evaluation of this extract, a group only received dose 256 mg/kg. Results. The plant extract was rich of phenolic compounds (), whereas it contained fewer amounts of flavonoids (). Results of in vitro experiments showed that there is an inverse relationship between the concentrations and the mortality of the parasites (). The highest percentage (62%) of dead tachyzoites was seen at maximum concentration of the extract. A significant longevity (8.9 days) was belonged to mice orally administered extract dose (256 mg/kg/day).Conclusion. The ethyl acetate extract of A. calamus rhizomes had significant anti-Toxoplasma activities either in vitro or in vivo. It may be connected to high amount of phenolic compounds. We suggest that the effects of different fractions and the admin types of the extract will be evaluated on the parasite.
Toxoplasmosis is a zoonosis parasitic disease with worldwide prevalence which caused by an obligate intracellular protrozoan; Toxoplasma gondii. Clinical congenital manifestation of toxoplasmosis is abortion and premature birth, hydrocephalus, microcephaly, jaundice and also chorioretinitis, anemia, pneumonia, and intracranial calcification in infants. Toxoplasmosis can also cause severe disease in individuals with immunodeficiency such as HIV-positive and cancer and transplant patients due to treatment with immunosuppressive drugs [1–4].
The current treatment in toxoplasmosis associated a range of side effects such as toxicity in pregnancy and bone marrow suppression, requirement of long courses, and lack of effect on the parasite cystic forms . Due to the toxicity of chemical drugs and people’s tendency to use traditional drugs and routs, many studies have been done on medicinal herbs and traditional methods in the world . Acorus calamus (sweet flag) has used as traditional medicinal herb in China and India. The American native people, the dried root and its powder, put into up the nose for inhibition of inflammation of the mucous membrane [5, 7]. The other pharmacological properties of A. calamus contain anti-inflammatory, antipyretic, antidiarrhoeal, antimutagenic, anticellular and immunosuppressive, larvicidal, antimicrobial, antiulcer, and cytoprotective . The rhizomes and leaf oils of A. calamus have been reported from the lower Himalayan region of India, with the major compounds in the rhizome oil, while β-asarone and linalool in the leaf oil . Joshi et al. showed the essential oil of A. calamus and its major compound β-asarone that has a bactericidal property against pathogen bacteria and fungi . Anthelmintic and antibacterial properties of rhizome are probably belonged to phenylpropanoid β-asarone . This study was conducted to determine effects of ethyl acetate extract of subterranean parts of Acorus calamus on Toxoplasma gondii in vivo and in vitro.
2. Material and Methods
2.1. Ethics Approval
The present study is based on guidelines for the care and use of laboratory animals . The Ethics Committee of Animal Experiments of the Shiraz University of Medical Sciences approved this research project (permit number IR.SUMS.REC.1398.355).
2.2. Collection of Samples
Several batches of rhizome of the fresh plant of Acorus calamus were prepared from regions of high altitude of forest in Sari city, northern Iran, in March 2015. Identification was carried out in Faculty of Pharmacy, Shiraz University of Medical Sciences. The parts of the plant were dried and grinded to powder. The plant herbarium specimens are collected in Payam Noor University of Mazadaran, and the dried rhizomes samples (Number: MPRCM-94-87) are maintained in Medicinal Plants Processing Research Center, Shiraz University of Medical Sciences.
Rhizomes of the plant were dried in shade (26°C, 2 weeks). To prepare the ethyl acetate extract, 30 g powder of the dried parts was poured in dark sterilized kartush containing 600 ml of ethyl acetate. The extract was provided using Soxhlet extractor. Each step of Soxhletation elongated approximately 6 hours. The extraction was concentrated with rotary evaporator apparatus and then dried by speed vacuum during 48 hours. The extract was maintained in dark bottle at 2-8°C condition.
The virulent RH strain of T. gondii was obtained from Tehran University of Medical Sciences, Tehran, Iran. Tachyzoites of the RH strain of T. gondii were maintained by serial intraperitoneal passaging in BALB/c inbred mice. After 72 hours, 106 parasite inoculation in the mice, the tachyzoites were collected after repeated flushing of the peritoneal cavity by phosphate buffered saline (PBS) at a pH of 7.2. Then, tachyzoites were harvested and centrifuged for 5 min at 200 g at room temperature to remove peritoneal cells and cellular debris. The supernatant was collected and centrifuged for 10 min at 800 g . The pellet, enriched with parasite tachyzoites, was recovered with PBS and used in the experiments.
2.5. Extracellular Viability Assay
We dissolved the extract in DMSO and then PBS to obtain a final concentration of 10 mg/ml. The final concentration of DMSO should not exceed 1%. Various concentrations (25, 50, 100, 200, 400, 800 μg/ml) of the extract were then prepared by the following: 2.5-80 μl of the final concentration was added to 920-997.5 μl of PBS that contained tachyzoites. Tachyzoites were incubated with either DMSO (as control) or the diluted compounds for 1.5 h at 4°C. Next, the tachyzoites were collected in Eppendorf tubes and incubated for 30 min at 4°C with 50 μg/ml propidium iodide (PI, Sigma Company, USA). After incubation, the parasites were kept on ice and in the dark until analysis. Positive controls for PI staining were acquired by incubating parasites in the presence of 0.2% saponin. The cell suspension was transferred into polystyrene flowcytometry tubes (BD Falcon Company, USA). We performed data acquisition and analysis, with a FACS Calibur flow cytometer (Becton-Dickinson, San Jose, USA) and Cell Quest Pro software. A total of 1000-30000 events were acquired in the region that had been previously established as corresponding to the parasites . All of the tests were undertaken in duplicate.
2.6. In Vivo Experiments
In this study, a total of 9 groups including 10 BALB/c inbred mice were considered. tachyzoites were intradermally inoculated into 8 groups including 10 mice. Based on results of in vitro experiments, 6 groups, doses 32, 64, 128, and 256 mg/kg, were orally, and doses 128 and 256 mg/kg, intraperitoneally administered: VII—received sulphadiazine as positive control and VIII—received PBS including DMSO 1%. These concentrations were daily administrated 24 hours after inoculation due 10 days continuously. Mice were followed for 15 days after inoculation. If the mice died, their liver touch smears were stained with Giemsa stain and observed under light microscopy for parasite detection .
2.7. The Acute Toxicity Assay of the Extract
For toxicity evaluation of this extract, a group only received a maximum dose of (256 mg/kg). Then, the mice were followed for any manifestation including paw licking, stretching of the entire body, salivation, weakness, respiratory distress, sleep, coma, and death in the first four hours and subsequently daily for 14 days.
2.8. Assessment of the Total Phenolic Content in the Extract
The total phenolic content of the extract was measured by the Folin–Ciocalteu method and Folin’s phenol reagent. In this experiment, garlic acid was used as standard. First, a serial dilution of garlic acid (0.024, 0.03, 0.075, 0.105 mg/ml) was provided by methanol and then filtered by Whatman Grade 1 filter paper. 0.5 ml of the different concentrations was diluted by 2.5 ml of Folin–Ciocalteu reagent and 2 ml of 7.5% (w/v) sodium carbonate in 20°C. Absorbance was measured at 765 nm. All of the tests were undertaken in triplicate, and calibration curve was drawn. 500 μL of the crude extract was diluted by 2.5 ml of Folin–Ciocalteu reagent and 2 ml of 7.5% (w/v) sodium carbonate in 20°C. Absorbance was measured at 765 nm. The total phenolic content was calculated from the calibration curve.
2.9. Total Flavonoid Content
250 mg of dried powder was diluted with 20 ml and sonicated for 15 minutes. The extract was filtered, and 5 ml of it was mixed with 5 ml of 2% (w/v) AlCl3 solution for 15 minutes in dark condition. Absorbance was measured at 415 nm. The total flavonoid content was calculated from a calibration curve obtained from quercetin.
2.10. Data Analysis
Data were gathered in SPSS software (version 16, Chicago, USA). In vitro results were analyzed by the Kuruskal–Wallis and Spearman correlation tests, whereas Kaplan-Meier and log rank (Mentel-Cox) were used in vivo. was considered statistically significant.
In this study, the mortality of Toxoplasma tachyzoite cells exposed to the different concentrations of ethyl acetate extract of Acorus calamus was measured using the flowcytometry technique.
Figures 1 and 2 show that there is an inverse relationship between the concentrations and mortality rate of the parasite tachyzoite. More than 62 percent of Toxoplasma tachyzites were killed at maximum concentration (256 μg/ml). IC50 of the extract on the parasite was calculated (μg/ml).
In vivo results showed a significant difference at maximum concentration (256 mg/kg) with gavage administration (), whereas peritoneal inoculation of this concentration did not effect on longevity of the mice.
Any signs of physical changes that belonged to the toxicity of the extract in the tested animals were not detected, and the entire mice group was live (Table 1).
shows death event.
Figure 3 shows the phenolic compound content of the extract based on standard graph of gallic acid. The plant extract was rich of phenolic compounds ().
Figure 4 shows the flavonoid compound content of the extract based on standard graph of quercetin. The flavonoid compound content of plant extract was .
Acorus calamus is consumed in traditional medicine, and its rhizomes are widely used to subside in clinical signs such as chronic diarrhea, dysentery, fever, and rheumatism . Also, it is used traditionally in the treatment of various ailments including neuralgia, dyspepsia, kidney and liver troubles, eczema, sinusitis, asthma, bronchitis, hair loss, and other disorders .
In vivo results of our experiments on the extract toxicity showed that any clinical signs were not occurred in the tested animals. Similarly, Muthuraman et al. showed that the high doses of the hydroalcoholic extract of the plant rhizome could not create any toxic effects in rats . Another study has shown that the high dose of the extract is very well tolerated in rodents but it is associated with a mild elevation in levels of the liver enzymes .
In our study, the ethyl acetate extract of the rhizome was rich of phenolic compounds. It has commonly been assumed that the plant pharmacological fundamentals such as antidepressant, antianxiety, anti-Alzheimer’s, anti-Parkinson’s, antiepileptic, anticancer, antihyperlipidemic, antithrombotic, anticholestatic, and radioprotective activities were related to phenolic compounds such as α and β-asarone molecules. Alpha and beta asarones are chemical compounds of the phenyl propanoid class [14, 17, 18]. Isoeugenol, another phenolic compound, is found in A. calamus leave samples .
Oliveira et al. showed that the mortality in mice with toxoplasmosis can be inhibited by phenolic compounds such as vanillin . Moreover, Choi et al. indicated that the phenolic compounds of ginger root extract can inactivate apoptotic proteins in host cells infected to Toxoplasma. Remarkably, the proteins inhibit secretion of inflammatory cytokines in vivo .
In this study, we measured a low content of the flavonoid compounds in the plant extract, but in other studies, apigenin, luteolin, and diosmetin as flavonoid compounds were found in A. calamus . Mac Laren et al. showed that some flavonoids, such as apigenin and genistein, can inhibit Toxoplasma growth due to inhibition of protein tyrosine kinase . Similarly, other flavonoid compounds such as naringenin and genistein had the notable activities against Cryptosporidium in cell culture .
Quercetin as a flavonoid compound can inhibit synthesis protection factors such as Hsp90, Hsp70, and Hsp27, and consequently, Toxoplasma remains sensitive due to the effects of host immune responses .
Lehane and Saliba showed that certain common dietary flavonoids especially luteolin can inhibit the intraerythrocytic growth of the chloroquine-sensitive and chloroquine-resistant strains of P. falciparum .
In our study, the direct effect of the different concentrations of ethyl acetate extract of A. calamus on Toxoplasma tachyzoite was measured using the flowcytometry technique. In this technique, the propidium iodide, a fluorescent DNA-binding dye, is used for the evaluation of dying cells. The results showed an inverse relationship between the concentrations and the mortality rate of the parasites.
In vivo results showed a significant difference at maximum concentration with gavage administration, whereas peritoneal inoculation of this concentration did not effect on longevity of the mice. However, the effect of peritoneal administration of concentration 128 μg/ml was better than oral concentration.
Our study demonstrated that Acorus calamus extract had significant activities against T.gondii in vivo and in vitro which may be connected to high amount of phenolic compounds. We suggest that the effects of the various fractions of this extract on the parasite are investigated. Alternatively, the administration types and dosage of the extract on the parasite must be evaluated.
The data used to support the findings of this study are available from the corresponding author upon request.
Conflicts of Interest
The authors declare that there is no conflict of interests.
The authors would like to thank the Vice Chancellor for Research Affairs of Shiraz University of Medical Sciences for financially supporting this project. They would also like to thank the staff of the Animal Laboratory Center for development of experimental studies.
- Q. Asgari, H. Keshavarz, M. Rezaeian, H. Sadeghpour, R. Miri, and M. H. Motazedian, “Anti-toxoplasma activity of 2-(Naphthalene-2-γlthiol)-1H Indole,” Iranian Journal of Parasitology, vol. 10, no. 2, pp. 171–180, 2015.
- F. Robert-Gangneux and M.-L. Dardé, “Epidemiology of and diagnostic strategies for toxoplasmosis,” Clinical Microbiology Reviews, vol. 25, no. 2, pp. 264–296, 2012.
- J. P. Dubey, “The history of Toxoplasma gondiiâThe first 100 years,” Journal of Eukaryotic Microbiology, vol. 55, no. 6, pp. 467–475, 2008.
- C. D. Dupont, D. A. Christian, and C. A. Hunter, “Immune response and immunopathology during toxoplasmosis,” Seminars in Immunopathology, vol. 34, no. 6, pp. 793–813, 2012.
- P. H. Alday and J. S. Doggett, “Drugs in development for toxoplasmosis: advances, challenges, and current status,” DDDT, vol. Volume11, pp. 273–293, 2017.
- R. Palacios, L. E. Osorio, L. F. Grajalew, and M. T. Ochoa, “Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species,” American Journal of Tropical Medicine and Hygiene, vol. 64, no. 3, pp. 187–193, 2001.
- P. K. Mukherjee, V. Kumar, M. Mal, and P. J. Houghton, “Acorus calamus: scientific validation of ayurvedic tradition from natural resources,” Pharmaceutical Biology, vol. 45, no. 8, pp. 651–666, 2008.
- V. Sharma, I. Singh, and P. Chaudhary, “Acorus calamus (the healing plant): a review on its medicinal potential, micropropagation and conservation,” Natural Product Research, vol. 28, no. 18, pp. 1454–1466, 2014.
- V. K. Raina, S. K. Srivastava, and K. V. Syamasunder, “Essential oil composition ofAcorus calamus L. from the lower region of the Himalayas,” Flavour and Fragrance Journal, vol. 18, no. 1, pp. 18–20, 2003.
- R. K. Joshi, “Acorus calamus Linn.: phytoconstituents and bactericidal property,” World Journal of Microbiology and Biotechnology, vol. 32, no. 10, p. 164, 2016.
- L. J. McGaw, A. K. Jäger, and J. van Staden, “Isolation of β-asarone, an antibacterial and anthelmintic compound, from Acorus calamus in South Africa,” South African Journal of Botany, vol. 68, no. 1, pp. 31–35, 2002.
- National Research Council, Guide for the Care and Use of Laboratory Animals, vol. 10, National Academies Press (US), 2010, 17226/12910.
- Q. Asgari, H. Keshavarz, S. Shojaee et al., “In vitro and in vivo potential of RH strain of Toxoplasma gondii (Type I) in tissue cyst forming,” Iranian Journal of Parasitology, vol. 8, no. 3, pp. 367–375, 2013.
- A. D. Khwairakpam, Y. D. Damayenti, A. Deka et al., “Acorus calamus: a bio-reserve of medicinal values,” Journal of Basic and Clinical Physiology and Pharmacology, vol. 29, no. 2, pp. 107–122, 2018.
- A. Muthuraman, N. Singh, and A. S. Jaggi, “Effect of hydroalcoholic extract of Acorus calamus on tibial and sural nerve transection-induced painful neuropathy in rats,” Journal of Natural Medicines, vol. 65, no. 2, pp. 282–292, 2011.
- A. Muthuraman and N. Singh, “Acute and sub-acute oral toxicity profile of Acorus calamus (sweet flag) in rodents,” Asian Pacific Journal of Tropical Biomedicine, vol. 2, no. 2, pp. S1017–S1023, 2012.
- R. Chellian, V. Pandy, and Z. Mohamed, “Pharmacology and toxicology of α- and β-Asarone: a review of preclinical evidence,” Phytomedicine, vol. 32, pp. 41–58, 2017.
- R. Chellian and V. Pandy, “Protective effect of α-asarone against nicotine-induced seizures in mice, but not by its interaction with nicotinic acetylcholine receptors,” Biomedicine & Pharmacotherapy, vol. 108, pp. 1591–1595, 2018.
- J. Radušienė, A. Judžentienė, D. Pečiulytė, and V. Janulis, “Essential oil composition and antimicrobial assay of Acorus calamus leaves from different wild populations,” Plant Genetic Resources, vol. 5, no. 1, pp. 37–44, 2007.
- C. B. Oliveira, Y. S. Meurer, T. L. Medeiros et al., “Anti-Toxoplasma activity of estragole and thymol in murine models of congenital and noncongenital toxoplasmosis,” Journal of Parasitology, vol. 102, no. 3, pp. 369–376, 2016.
- W. Choi, M. Jiang, and J. Chu, “Antiparasitic effects of Zingiber officinale (ginger) extract against Toxoplasma gondii,” Journal of Applied Biomedicine, vol. 11, no. 1, pp. 15–26, 2013.
- S. S. Selçuk, M. Bahar, and A. H. Meriçli, “The flavonoid compounds from the leaves of Acorus calamus growing in Turkey,” Acta Pharmaceutica Sciencia, vol. 51, no. 1, pp. 83–85, 2009.
- A. MacLaren, M. Attias, and W. De Souza, “Aspects of the early moments of interaction between tachyzoites of Toxoplasma gondii with neutrophils,” Veterinary Parasitology, vol. 125, no. 3-4, pp. 301–312, 2004.
- J. R. Mead and N. McNair, “Antiparasitic activity of flavonoids and isoflavones against Cryptosporidium parvum and Encephalitozoon intestinalis,” FEMS Microbiology Letters, vol. 259, no. 1, pp. 153–157, 2006.
- C. A. Dobbin, N. C. Smith, and A. M. Johnson, “Heat shock protein 70 is a potential virulence factor in murine Toxoplasma infection via immunomodulation of host NF-kappa B and nitric oxide,” Journal of Immunology, vol. 169, no. 2, pp. 958–965, 2002.
- A. M. Lehane and K. J. Saliba, “Common dietary flavonoids inhibit the growth of the intraerythrocytic malaria parasite,” BMC Research Notes, vol. 26, no. 1, pp. 1–5, 2008.
Copyright © 2021 Maryam Nikkhoo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.